Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionNemes Rush Group LLC
Latest Disclosed Ownership26,940 shares
Latest Disclosed Value $ 3,754,659
Nemes Rush Group LLC reports 0.63% increase in ownership of GILD / Gilead Sciences, Inc.

On April 21, 2026 - Nemes Rush Group LLC filed a 13F-HR form disclosing ownership of 26,940 shares of Gilead Sciences, Inc. (CH:GILD) valued at $3,754,659 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 26,772 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.63% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F GILEAD SCIENCES COM 375558103 26,940 168 0.63 3,755 14.28 0.3567
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 26,772 264 1.00 3,286 11.66 0.3089
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 26,508 4,158 18.60 2,942 18.77 0.2915
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 22,350 21,612 2,928.46 2,478 2,920.73 0.2698
2025-05-07 2025-03-31 13F GILEAD SCIENCES COM 375558103 738 0 0.00 83 20.59 0.0104
2025-02-12 2024-12-31 13F GILEAD SCIENCES COM 375558103 738 -5,858 -88.81 68 -85.92 0.0084
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 6,596 5,715 648.69 483 705.00 0.0701
2024-08-15 2024-06-30 13F GILEAD SCIENCES COM 375558103 881 -5,740 -86.69 60 -87.60 0.0083
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 6,621 -23,220 -77.81 485 -79.98 0.0694
2024-02-09 2023-12-31 13F GILEAD SCIENCES COM 375558103 29,841 -230 -0.76 2,417 7.28 0.3897
2023-11-09 2023-09-30 13F GILEAD SCIENCES COM 375558103 30,071 -290 -0.96 2,253 -3.68 0.4084
2023-08-02 2023-06-30 13F GILEAD SCIENCES COM 375558103 30,361 30,361 2,340 0.4125
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.